The program spotlights Sunstone Therapies, a clinical research organization operating out of the Adventist HealthCare Shady Grove Aquilino Cancer Center in Rockville, Maryland. By applying rigorous oncology-based protocols to psychedelic treatments, the clinic emphasizes that the therapeutic value lies not merely in the substance itself, but in the comprehensive support system of preparation, supervised administration, and integration.

"Many of the patients we work with have spent years trying different forms of treatment without meaningful relief," says Manish Agrawal, M.D., CEO and cofounder of Sunstone Therapies. He notes that the primary objective is ensuring patients navigate their experiences within a grounded, medically supervised framework rather than in isolation.

The segment explores the logistical and clinical hurdles of embedding these practices into the current healthcare system. By prioritizing standardized training and clear clinical pathways, the producers aim to distinguish evidence-based psychedelic medicine from non-medical applications, advocating for a future where patient safety remains the central pillar of mental health innovation.